Europe’s FOAK bio-based plants cross second valley of death
In Belgium, new study shows how Europe’s first-of-a-kind (FOAK) bio-based plants made it across the second valley of death, securing feedstock, finance and off-take. The study, Winning the First-of-a-Kind Challenge, was produced by the Bio-based Industries Consortium (BIC) and authored by Melich Seefeldt. Drawing evidence from UPM, Avantium and Fibenol, whose projects moved from investment decision to physical plant, the study highlights three routes to a FOAK surviving the second valley of death:
corporate-backed industrial deployment, listed technology-platform scale-up, and project-led lignocellulosic commercialisation.
FOAK plants are the bridge between a technology that works in the lab and an industry that works at scale: without a first plant, a new technology never reaches the market. That makes them decisive for the EU Bioeconomy Strategy, envisaging a wide deployment of bio-based materials and products in the EU by 2040. Given how long it takes to build and ramp up a plant, 2040 is effectively tomorrow.
The study identifies four measures that helped these projects succeed:
• Funding must cover the phase after construction, when the plant is commissioned and ramped up;
• Starting with one controlled feedstock route and widening it later leads to faster learning;
• Successful projects relied on binding or conditioned off-take agreements, which give stronger evidence to financiers;
• Policy can help determine whether the sustainable value of a first plant is recognised by customers and investors, through bio-based carbon recognition, credible claims and workable certification.
The study also calls for a strong EU budget for the bioeconomy for 2028-2034 and for patient capital from public and private sources. Where customers are unwilling to pay a green premium, public policy can improve market conditions through mandates, targets and public procurement.
Category: Fuels








